News

A new combination of treatments safely decreased growth of pancreatic cancer in mice by preventing cancer cells from scavenging for fuel, a new study finds.

In cases where standard therapies fail, an investigational medication called XEN1101 reduces seizure frequency by more than 50 percent in some patients and sometimes eliminates them altogether, a new study shows.

Researchers have investigated how the toxin emerged between 50 and 120 million years ago through the modification of a gene that also occurs in mammals and other reptiles.

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer. In mouse models of melanoma, bladder cancer, leukemia and colon cancer, the drug slows the growth of tumors, and boosts the efficacy of immunotherapy.

Contraceptive pills can reduce the risk of rheumatoid arthritis, while hormone treatment in connection with menopause can increase the risk later in life.

A new clinical trial has shown that ketamine nasal spray treatment in patients with treatment-resistant depression led to higher rates of remission than standard intervention with the antipsychotic drug quetiapine.

New research validates that pyrvinium, a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.

They’re being hailed as an effective way to lose weight, but diabetes drugs like Ozempic may come with a heightened risk of severe gastrointestinal problems.

Researchers have shown the potential of a new gene therapy approach to silence human nerve cells as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.

A landmark study analyzing over 54,000 samples from the UK Biobank has been published in Nature. Conducted by the Pharma Proteomics Project, it is the largest body of work analyzing the effects of common gene variations on blood proteins.